Identification of factors associated with primary refractoriness to atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma
Titel:
Identification of factors associated with primary refractoriness to atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma
Auteur:
Manfredi, G.F. Fulgenzi, C.A.M. D'Alessio, A. Celsa, C. Stefanini, B. Cheon, J. Ang, C. Marron, T.U. Saeed, A. Wietharn, B. Pressiani, T. Pinter, M. Scheiner, B. Huang, Yi-Hsiang Phen, S. Naqash, A. Rafeh Piscaglia, F. Lin, R. Po-Ting -yen Lin, C. Dalbeni, A. Vivaldi, C. Masi, G. Thimme, R. Vogel, A. Schönlein, M. von Felden, J. Schulze, K. Wege, H. Galle, P.R. Kudo, M. Rimassa, L. Singal, A. Sharma, R. Cortellini, A. Jae Chon, H. Burlone, M. Pirisi, M. Pinato, D.J.